Our studies have demonstrated no relationship between intensity of AT-1R expression and some clinicopathological parameters, i.e. grade of malignancy, primary tumour size, presence of lymph node metastases, menopausal status or expression of ER, PR and HER2 receptors. Here, ESR1 is linked to metastatic malignant neoplasm in the lymph nodes.